Skip to content

Clinical trials

Migraine Disorders trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: Switzerland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20152
20161
20173
20191
20211
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich3
Ente Ospedaliero Cantonale, Bellinzona2
University Hospital, Basel, Switzerland2
AbbVie1
Abbott Medical Devices1
Allergan1
Amgen1
Eli Lilly and Company1
Insel Gruppe AG, University Hospital Bern1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders19
Headache4
Epilepsy2
Recurrence2
Altitude Sickness1
Chronic Pain1
Endometriosis1
Foramen Ovale, Patent1
Headache Disorders1
Migraine with Aura1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.